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a b s t r a c t
3-Methylglutaconic aciduria (MGTA) comprehends a group of disorders biochemically characterized
by accumulation of 3-methylglutaric acid (MGA), 3-methylglutaconic acid (MGT) and occasionally
3-hydroxyisovaleric acid (OHIVA). Although neurological symptoms are common in the affected indi-
viduals, the mechanisms of brain damage are poorly known. In the present study we investigated the
in vitro effect MGA, MGT and OHIVA, at concentrations ranging from 0.1 to 5.0mM, on bioenergetics and
oxidative stress in synaptosomal preparations isolated from cerebral cortex of young rats. MGA signiﬁ-
cantly reduced mitochondrial redox potential (25%), as determined by resazurin reduction, and inhibited
the activity ofNa+,K+-ATPase (30%),whereasMGTandOHIVAdidnotmodify theseparameters.Moreover,
the inhibitory effect elicited by MGA on Na+,K+-ATPase activity was totally prevented by co-incubationxidative stress with the scavenging antioxidants creatine and melatonin, implying a role for reactive species in this
effect. MGA also increased 2′,7′-dichloroﬂuorescein (DCFH) oxidation (30%), reinforcing that this organic
acid induces reactive species production. The present data indicate that MGA compromises mitochon-
drial function, elicits reactive species production and inhibits the activity of a crucial enzyme implicated
in neurotransmission. It is therefore presumed that these deleterious effectsmay play a role in the patho-
physiology of the brain damage observed in patients affected by disorders in which MGA accumulates.. Introduction
3-Methylglutaconic (MGTA) aciduria (MGTA) comprehends a
roup of disorders biochemically characterized by tissue accu-
ulation and increased urinary excretion of 3-methylglutaconic
MGT) and 3-methylglutaric (MGA) acids. MGTA type I is
aused by deﬁciency in the activity of 3-methylglutaconyl-
oA hydratase, which converts 3-methylglutaconyl-CoA into
-hydroxy-3-methylglutaryl-CoA (HMG-CoA). PatientswithMGTA
ype I generally present microcephaly, progressive neurological
mpairment with spastic quadriplegia, psychomotor retardation,
Abbreviations: MGTA, 3-methylglutaconic aciduria; MGA, 3-methylglutaric
cid; MGT, 3-methylglutaconic acid; OHIVA, 3-hydroxyisovaleric acid; DCF-DA,
′ ,7′-dichloroﬂuorescein diacetate; Cre, creatine; Mel, melatonine; SPSS, Statistical
ackage for the Social Sciences.
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seizures and dystonia, as well as delayed speech, hypoglycemia
and metabolic acidosis (Arn and Funanage, 2006; Di Rosa et al.,
2006; IJlst et al., 2002; Shoji et al., 1999; Sweetman and Williams,
2001). BesidesMGTandMGA, individualswithMGTA type I excrete
increased amounts of 3-hydroxyisovaleric acid (OHIVA) in their
urine (IJlst et al., 2002). MGTA type II, also referred as Barth syn-
drome, is an X-linked mitochondrial disorder caused by mutations
in the gene encoding tafazzin (TAZ). Affected individuals have car-
diomyopathy, neutropenia and growth retardation (Barth et al.,
2004). Type III or Costeff syndrome is an autosomal recessive dis-
order caused by mutations in the OPA3 gene, leading to bilateral
optic atrophy (Anikster et al., 2001; Arn and Funanage, 2006).
Type IVor “unspeciﬁed”MGTAcomprises aheterogeneousdisorder
with progressive mental and psychomotor retardation, spasticity,
hypertonicity, and cardiomyopathy (Besley et al., 1995; Ibel et al.,
1993; Ruesch et al., 1996).Interestingly, some patients with MGTA
Open access under the Elsevier OA license.have elevated lactic acid or/and citric acid cycle intermediates, as
well as abnormalities of themitochondrial electron transport chain
(Besley et al., 1995; Ibel et al., 1993; Ruesch et al., 1996), including
deﬁciency of the activities of respiratory chain complexes I, II, III,
IV and V (Gibson et al., 1993; Gunay-Aygun, 2005; Sweetman and
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illiams, 2001; Wortmann et al., 2006), indicative of a mitochon-
rial dysfunction.
Although neurological abnormalities are relatively common in
GTA, the underlying mechanisms of brain damage in this dis-
rder are poorly known. However, it was recently reported that
GT, MGA and OHIVA induce oxidative lipid and protein dam-
ge and reduce the brain antioxidant defenses in cerebral cortex
f rats (Leipnitz et al., 2008). In the present work we investigated
he in vitro effects of MGA, MGT and OHIVA on viability, mito-
hondrial function,Na+,K+-ATPaseactivity and reactive species (RS)
ormation in synaptosomal preparations from cerebral cortex of
oung rats. It is emphasized that synaptosomes are isolated neuron
erminals that contain all the cell machinery needed for synap-
ic transmission, includingmitochondria necessary formaintaining
nergy metabolism.
. Materials and methods
.1. Animals and reagents
A total of 55 30-day-old male Wistar rats obtained from the Central Animal
ouse of the Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde,
niversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, were used. The ani-
als were maintained on a 12:12h light/dark cycle in an air-conditioned constant
emperature (22 ◦C±1 ◦C) colony room, with food and water ad libitum. The exper-
mental protocol was approved by the Ethics Committee for Animal Research of the
niversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (protocol number
0-351), and followed the “Principles of Laboratory Animal Care” (NIH publication
5-23, revised 1985). All effortsweremade tominimize the number of animals used
nd their suffering. The chemicals usedwere of analytical grade and purchased from
igma Co. (St Louis, MO, USA), except for MGT and OHIVA (99% purify), which were
repared by Dr. Ernesto Brunet, Universidad Autonoma de Madri, Spain. MGT, MGA
nd OHIVA solutions were prepared on the day of the experiments in the incuba-
ion medium used for each technique and the pH was adjusted to 7.2. The ﬁnal
oncentrations of the acids in the medium ranged from 0.1 to 5.0mM.
.2. Synaptosomal preparation
Brain synaptosomal fractions represent a suitable preparation for in vitro exper-
ments as they functionally behave as minicells. Synaptosomes were obtained from
at cerebral cortex according to a previous report (Springer et al., 1998). Brieﬂy, ani-
als were killed by decapitation without anesthesia and the cerebral cortex was
issected and homogenized in 15mL of an ice cold 0.32M sucrose solution con-
aining 2mM EDTA, 2mM EGTA, and 20mM Hepes, pH 7.2. The homogenate was
entrifuged at 450× g for 10min at 4 ◦C and the supernatant transferred to a new
ube. The remaining pellet was suspended in 15mL homogenization buffer and cen-
rifuged as before. The two supernatant fractions were combined and centrifuged at
0,000× g for 10min at 4 ◦C and the resulting crude synaptosomal pellet was then
uspended in 0.8mL of Locke’s buffer (154mM NaCl, 5.6mM KCl, 2.3mM CaCl2,
.0mM MgCl2, 3.6mM NaHCO3, 5mM glucose, 5mM Hepes, pH 7.2).
.3. Synaptosomal incubation
Cortical synaptosomal preparations were freshly employed in the experiments.
liquots of 600L (0.5mg protein) were incubated in 24-well plates at 37 ◦C for 1h
n a shaking water bath in the presence of MGA, MGT or OHIVA (0.1–5.0mM). Con-
rols did not contain these organic acids in the incubation medium. At the end of the
ncubation period, the medium was centrifuged and the pellets washed, suspended
n Locke’s buffer and stored at −80 ◦C for further biochemical analysis.
.4. Lactate dehydrogenase (LDH) measurement
Synaptosomal plasma membrane integrity and viability was analyzed by mon-
toring the activity of the cytoplasmic enzyme LDH in the extracellular incubation
edium. LDH activity was measured spectrophotometrically according to the
ethod of Bergmeyer and Brent (1974) by following the rate of conversion of NADH
o NAD+ at 340nm. LDH leakage was expressed as a percentage of total LDH release.
otal LDH release (100% release) was achieved with 0.1% Triton X-100 in the incu-
ation medium.
.5. Estimation of mitochondrial function by resazurin reductionResazurin reduction in synaptosomal preparations was performed as described
reviously (Springer et al., 1998) with minor modiﬁcations. Synaptosomal prepara-
ions (50g) were pipetted into a 96-well plate in a ﬁnal volume of 300L in the
resence of MGA, MGT or OHIVA. Ten L of 0.1% resazurin were added and ﬂuo-
escence levels were measured at 60min following incubation using a SpectraMaxuroscience 29 (2011) 1–7
M5 ﬂuorescence plate reader at 530nm excitation and 590nm emission. Triplicate
samples from at least ﬁve independent experiments were used to examine changes
in resazurin ﬂuorescence levels. Samples containing equal amounts of Locke’s buffer
with the addition of resazurin were used to obtain the background signal. Results
were calculated as arbitrary ﬂurorescence units per mg protein and expressed as
percentage of control.
2.6. Na+,K+-ATPase activity measurement
The reactionmixture for theNa+,K+-ATPaseassay contained5mMMgCl2, 80mM
NaCl, 20mM KCl, 40mM Tris–HCl buffer, pH 7.4 and approximately 5g of protein
from frozen-thawed synaptosomal preparations in a ﬁnal volume of 200L in 96-
well plates. The enzymatic assay carried out at 37 ◦C during 10min was started
by the addition of ATP (disodium salt, vanadium free) to a ﬁnal concentration of
3mM.The reactionwas stoppedby the additionof 100Lof 15% trichloroacetic acid.
Mg2+-ATPase ouabain-insensitive was assayed under the same conditions with the
addition of 1mM ouabain. Na+,K+-ATPase activity was calculated by the difference
between the two assays (Tsakiris and Deliconstantinos, 1984). Released inorganic
phosphate (Pi) was measured by the method of Chan et al. (1986). In some exper-
iments the antioxidants creatine (Cre, 0.1mM) or melatonin (MEL, 0.1mM) were
co-incubated with 5 MGA. Enzyme-speciﬁc activities were calculated as nmol Pi
released/min/mg protein and expressed as percentage of control.
2.7. Determination of ROS formation
Reactive species formation was measured in synaptosomal fractions according
to Silva-Adaya et al. (2008). Brieﬂy, synaptosomal preparations (100g protein)
were incubated with 5mol/L 2′ ,7′-dichloroﬂuorescein (DCF) diacetate reagent at
37 ◦C for 60min in the presence of the metabolites. At the end of incubation, ﬂuo-
rescent signals were recorded at excitation and emission wavelengths of 488 and
532nm, respectively, in a SpectraMax M5 plate reader. Results were calculated as
arbitrary ﬂurorescence units permg protein and expressed as percentage of control.
2.8. Determination of thiobarbituric acid-reactive substances (TBA-RS)
TBA-RS levels were assayed according to the method described by Yagi (1998)
with slight modiﬁcations. Brieﬂy, 200L of 10% trichloroacetic acid and 300L of
0.67% TBA in 7.1% sodium sulfate were added to 100L of synaptosomal fractions
containing 100g protein and incubated for 1h in a boilingwater bath. Themixture
was allowed to cool on running tap water for 5min. The resulting pink-stained
complex was extracted with 400L butanol. Fluorescence of the organic phase was
read at 515nm and 553nm as excitation and emission wavelengths, respectively.
Calibration curve was performed using 1,1,3,3-tetramethoxypropane and subjected
to the same treatment as supernatants. TBA-RS levels were calculated as nmol TBA-
RS/mg protein.
2.9. Protein determination
Protein content was measured by the method of Bradford (1976), using bovine
serum albumin as standard.
2.10. Statistical analysis
Data were expressed as means± SEM for absolute values or percentage of con-
trol. Assays were performed in duplicate or triplicate and the mean or median was
used for statistical analysis. Data were analyzed using one-way analysis of variance
(ANOVA) followed by the post hoc Duncan multiple range test when F was signiﬁ-
cant. Differences betweengroupswere rated signiﬁcant at P<0.05. All analyseswere
carried out in an IBM-compatible PC computer using the Statistical Package for the
Social Sciences (SPSS) software.
3. Results
In this study, it was ﬁrst evaluated synaptosomal
integrity/viability by measuring LDH leakage into the extra-
cellular medium after 1 and 2h incubation of synaptosomal
preparations in the presence of various concentrations of MGA,
MGT or OHIVA. No signiﬁcant differences in LDH extracellular
concentrations, expressed as percentage of Triton X-100-treated
preparations, were observed in MGA-, MGT- or OHIVA-treated
synaptosomal preparations for 1 or 2h as compared to the control
(Fig. 1).
Synaptosomal mitochondrial function was also evaluated by
determining the decrease of resazurin ﬂuorescence (Nakai et al.,
2003). Fig. 2 (panel A) shows that MGA signiﬁcantly inhibited
resazurin reduction by up to 25% [F(3,32) =7.35, P<0.01] in a dose-
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Fig. 1. Effects of 3-methylglutaric (MGA), 3-methylglutaconic (MGT) and 3-
hydroxyisovaleric (OHIVA)on lactatedehydrogenase (LDH) release in synaptosomes
from cerebral cortex young rats. To achieve total LDH leakage (100%), synaptosomal
preparations were incubated in the presence of 0.1% Triton X-100. Data relatively
to 1h incubation are expressed as mean± SEM for 6 independent preparations
performed in triplicate and are expressed as percentage of total LDH leakage. No
signiﬁcant differences were observed between groups (one-way ANOVA).
Table 1
Effect of 3-methylglutaric acid (MGA) on TBA-RS levels in synaptosomal prepara-
tions from cerebral cortex of young rats.
Treatment TBA-RS measurement
Control 1.48 ± 0.05
MGA
0.1mM 1.36 ± 0.17
1.0mM 1.41 ± 0.11
5.0mM 1.42 ± 0.05
Synaptosomal preparations were incubated for 1h at 37 ◦C in the absence (con-
trols) or presence of various concentrations ofMGA. The extent of lipid peroxidation
was measured by TBA-RS production, as described in Section 2. Data are expressed
as mean± SEM for 4 independent preparations performed in triplicates and are
expressed as nmol TBA-RS/mg of protein. No signiﬁcant differences were observed
between groups (one-way ANOVA).
dependent manner (ˇ =−0.543, P<0.01), whereas MGT and OHIVA
did not alter this parameter (panels B and C).
The next step was designed to investigate the effects of MGA,
MGT and OHIVA on synaptosomal Na+,K+-ATPase activity, an
enzyme that is critical for the maintenance of membrane poten-
tial necessary for neurotransmission. MGA signiﬁcantly inhibited
the activity of Na+,K+-ATPase by up to 25% [F(3,30) =4.83; P<0.01]
(Fig. 3, panel A), in contrast to MGT and OHIVA, which did not
modify this enzyme activity (panels B and C).
The effects of MGA on RS formation accessed by 2′,7′-DCF diac-
etate oxidation were also evaluated. Fig. 4 demonstrates that MGA
signiﬁcantly increased RS formation (up to 30%) [F(2,23) =20.24;
P<0.001] in a dose dependent way (ˇ =0.756, P<0.001). Further-
more, in order to clarify the participation of reactive species in
the inhibitory effect elicited by MGA on Na+,K+-ATPase activity, we
investigated the role of the antioxidants creatine (Cre, 0.1mM) and
melatonin (MEL, 0.1mM) co-incubated separatelywith 5mMMGA.
As observed in Fig. 5, the tested antioxidants completely abolished
the inhibitory effect caused by MGA on Na+,K+-ATPase activity.
Finally, it was also tested the effect of MGA on TBA-RS levels, an
index of lipid peroxidation. We found no alteration of this param-
eter in synaptosomal preparations exposed for 1h to 0.1–5.0mM
MGA (Table 1).
4. Discussion
Patients affected by MGTA predominantly accumulate MGT and
MGA in their tissues and body ﬂuids, as well as OHIVA when the
disorder is causedby3-methylglutaconyl-CoAhydratasedeﬁciency
(MGTA type I). Although these individuals commonly present neu-
rologic manifestations, the pathophysiology of the brain damage
is poorly established. However, it could be presumed that MGT,
MGA and OHIVA are possibly associated with the brain damage
that occurs in MGTA since the cerebral symptoms become worse
during episodes of metabolic decompensation, in which a dra-
matic increase of the tissue concentrations of these organic acids
occurs.
Considering that mitochondrial dysfunction (Parker et al., 1990,
1994; Swerdlow et al., 1997, 1996) and oxidative stress (Behl and
Moosmann, 2002; Berg and Youdim, 2006; Bogdanov et al., 2001;
Mancuso et al., 2006; Stoy et al., 2005) have been implicated in
the pathophysiology of common neurodegenerative disorders and
also in some inborn errors of metabolism characterized by accu-
mulation of endogenous compounds (Barschak et al., 2006; da Silva
et al., 2002; de Oliveira Marques et al., 2003; Fontella et al., 2002;
Latini et al., 2002, 2005a, 2005b; Ribeiro et al., 2007; Wyse et al.,
2001, 1995), in the present investigation we evaluated the in vitro
effects of MGA, MGT and OHIVA on bioenergetics and oxidative
stress in synaptosomes from cerebral cortex of young rats. It is
emphasized that synaptosomes correspond to isolated nerve ter-
4 C.A.J. Ribeiro et al. / Int. J. Devl Neuroscience 29 (2011) 1–7
Fig. 2. Effects of 3-methylglutaric (MGA), 3-methylglutaconic (MGT) and 3-hydroxyisovaleric (OHIVA) on resazurin reduction in synaptosomes from cerebral cortex young
rats. Synaptosomal preparations containing resazurin were incubated at 37 ◦C for 60min in the absence (control) or presence of the organic acids. The background signals of
the dye were obtained in the absence of synaptosomes. The data were expressed as percentage of control and are represented as mean± SEM of 5–9 experiments performed
in triplicate. **P<0.01 compared to the control group (ANOVA followed by Duncan’s t-test).
F yisovaleric (OHIVA) on Na+,K+-ATPase activity in synaptosomes from cerebral cortex of
y sence (control) or presence of the organic acids. The data were expressed as percentage
o control group (ANOVA followed by Duncan’s t-test).
m
s
n
t
i
m
M
g
e
n
o
a
b
l
r
i
N
s
m
(
t
Fig. 4. Effects of 3-methylglutaric acid (MGA) on ROS formation in cerebral cortex
synaptosomes from cerebral cortex of young rats. Synaptosomal preparations wereig. 3. Effects of 3-methylglutaric (MGA), 3-methylglutaconic (MGT) and 3-hydrox
oung rats. Synaptosomal preparations were incubated at 37 ◦C for 60min in the ab
f control and are represented as mean± SEM (n=5–9). **P<0.01 compared to the
inals, in which mitochondria subsist in a physiological cytoplasm
urrounded by plasma membrane, with the whole cell machinery
ecessary for neurotransmission (Nicholls, 2003).
We initially observed that MGA, MGT or OHIVA, at concentra-
ions up to 5mM, did not cause LDH leakage to the extracellular
ncubation medium, suggesting that these organic acids did not
odify membrane integrity/viability in our experimental design.
oreover, the amount of LDH leakage observed in our control
roups was similar to those observed in previous reports (Cardoso
t al., 1999).
In contrast, resazurin reduction was decreased by MGA, but
ot by MGT and OHIVA, indicating a selective impairment of this
rganic acid on mitochondrial function. In this context, resazurin,
ﬂuorescent probe that acts as an intermediate electron acceptor
etween cytochrome oxidase and the ﬁnal reduction of molecu-
ar oxygen, is almost totally reduced in the mitochondria and the
edox potential of resazurin is considered an accurate and sensitive
ndication of mitochondrial function (Gonzalez and Tarloff, 2001;
akai et al., 2003; Springer et al., 1998). Similarly, pretreatment of
ynaptosomeswith themetabolic inhibitorsMPP+, sodiumcyanide,
alonate or antimycin A markedly reduce resazurin ﬂuorescence
Nakai et al., 2003; Springer et al., 1998). Therefore, considering
hat changes in resazurin ﬂuorescence are mainly associated with
incubated at 37 ◦C for 60min in the presence of 2′ ,7′-dichloroﬂuorescein (DCF) diac-
etate and in the absence (control) or presence of various concentrations ofMGA. The
background signals of the dye were obtained in the absence of synaptosomes. The
data were expressed as percentage of control and are represented as mean± SEM
(n=7). **P<0.01, ***P<0.001 compared to control group (ANOVA followed by Dun-
can’s t-test).
C.A.J. Ribeiro et al. / Int. J. Devl Ne
Fig. 5. Effects of creatine (Cre, 1mM) and melatonine (Mel, 0.1mM) on the inhi-
bition of Na+,K+-ATPase activity caused by MGA in cerebral cortex synaptosomes
from cerebral cortex of young rats. Synaptosomal preparations were co-incubated
at 37 ◦C for 60min in the absence or presence of Cre orMelwith 5mMMGA. The data
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Nere expressed as percentage of control and are represented as mean± SEM (n=5).
*P<0.01 compared to control group, #P<0.01 compared to MGA group (ANOVA
ollowed by Duncan’s t-test).
itochondrial redox activity, our present results indicate thatMGA
ompromises synaptosomal mitochondrial bioenergetics.
We also found that Na+,K+-ATPase, a critical enzyme necessary
ornormalneurotransmission (Kaplan, 2002)was selectively inhib-
ted by MGA in synaptosomal preparations, in contrast to MGT and
HIVA, which did not alter this enzyme activity.
Considering a previous report demonstrating that MGA induces
xidative damage (Leipnitz et al., 2008) and that membrane bound
a+,K+-ATPase is highly vulnerable to free radical attack (Jamme
t al., 1995; Kurella et al., 1997; Lees, 1993; Rauchova et al., 1999;
ousef et al., 2002), we tested the effect of antioxidants on the
GA-induced inhibition of Na+,K+-ATPase activity. Co-incubation
f synaptosomes with melatonin, which scavenge more efﬁciently
eroxyl and hydroxyl radicals, totally abolished the inhibition
aused by MGA, suggesting that these free radicals were mainly
esponsible for this effect. In this context, oxidation of sulfhydryl
r other essential groupsof theenzymeandalterationofmembrane
hospholipids by oxidation or by the interference of lipophilic
ubstances have been implicated in Na+,K+-ATPase inactivation
Fleuranceau-Morel et al., 1999; Lehotsky et al., 1999; Yufu et al.,
993).
We also observed that creatine was also able to fully prevent
GA-induced inhibition of Na+,K+-ATPase activity. It should be
oted that synaptosomes contain creatine transporters (Peral et al.,
010), implying that this compound can be easily transported
nto these particles, replenishing the phosphocreatine pool and
aintaining ATP levels stable. In this scenario, it is conceivable
hat the reestablishment of the energy status of the synapto-
omes could contribute to the neuroprotective effects of creatine as
ere demonstrated preventing MGA-elicited inhibition of Na+,K+-
TPase activity. It cannot be however rule out a protective effect of
reatine reducing RS generation since mitochondrial dysfunction
ay secondarily induce free radical formation. This view is sup-
orted by the antioxidant properties of creatine, which is able to
cavenge various species including the hydroxyl radical which is
he most toxic in vivo free radical (Sestili et al., 2006).
In order to further test this hypothesis, we evaluated the abil-
ty of MGA to induce RS formation in synaptosomes. We observed
hat cerebral cortex synaptosomes exposed to MGA resulted in an
nhanced DCFH oxidation, which is essentially dependent on reac-
ive species (Chenet al., 2010;KestonandBrandt, 1965), reinforcing
ree radical attack as a probable cause ofMGA-induced inhibition of
a+,K+-ATPase activity. In contrast, TBA-RS levels in synaptosomaluroscience 29 (2011) 1–7 5
preparations were not altered by MGA, implying that membrane
lipid peroxidation did not occur.
Considering thatMGAbarely penetrates into the cellmembrane
because it is a hydrophilic and polar molecule, allied to our results
demonstrating that MGA was not able to cause lipid peroxidation
underour conditions,wepresume thatNa+,K+-ATPase activity inhi-
bition elicited by MGA may be attributed to oxidation of essential
groups of the enzyme.
Relatively to the possible consequences of MGA-elicited inhi-
bition of Na+,K+-ATPase activity to neural cellular function, there
is increasing evidence suggesting that inhibition of Na+,K+-ATPase
activity is associated with neurodegeneration (Lees, 1991, 1993;
Satoh andNakazato, 1992; Sweadner, 1979; Benari, 1985; Choi and
Rothman, 1990; Cousin et al., 1995; de Freitas, 2010; Grisar, 1984;
Lees and Leong, 1995; Santos et al., 2010). Therefore, our present
results may possibly be implicated in the brain injury occurring in
patients that accumulate MGA (Arn and Funanage, 2006; Gunay-
Aygun, 2005; Shoji et al., 1999).
At present, we cannot ascertain the exact pathophysiological
relevance of our data since to our knowledge brain concentrations
of MGA in affected patients with MGTA are not yet established.
It should be also stressed that, although the concentrations of
this organic acid resulting in signiﬁcant alterations of the param-
eters investigated were relatively high, it has been proposed that
the concentrations of organic acids, particularly dicarboxylic acids
(including MGA) accumulating in various organic acidemias, are
much higher in the brain as compared to the serum because these
compounds are thought to be trapped in neural cells (Hoffmann
et al., 1993; Sauer et al., 2006; Stellmer et al., 2007). Further-
more, it is conceivable that the combination of various deleterious
effects provoked by MGA, including mitochondrial dysfunction,
inhibition of Na+,K+-ATPase activity and induction of reactive
species, may act synergistically to cause neuronal (synaptosomal)
damage.
In conclusion, the present study demonstrated for the ﬁrst
time that MGA, an organic acid that mainly accumulates in MGTA,
inhibits a crucial enzyme responsible for maintaining the basal
potential membrane necessary for a normal neurotransmission.
It was also shown that this organic acid selectively compromises
energy metabolism and induces reactive species formation. In case
our in vitro results could be extrapolated to the human condition, it
is feasible that these pathomechanisms might contribute, at least
in part, to the encephalopathy ofMGTAaffected patients, especially
during crises when the concentrations of this toxic metabolite dra-
matically increase (Arn and Funanage, 2006; Gunay-Aygun, 2005;
Shoji et al., 1999).
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